Outlook Therapeutics
OTLK
#9371
Rank
ยฃ66.38 M
Marketcap
ยฃ1.49
Share price
-2.93%
Change (1 day)
12.07%
Change (1 year)

Revenue for Outlook Therapeutics (OTLK)

Revenue in 2025 (TTM): ยฃ1.09 Million

According to Outlook Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ1.13 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Outlook Therapeutics from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ1.09 M
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A-100%
2019 ยฃ5.39 M102.53%
2018 ยฃ2.66 M-15.84%
2017 ยฃ3.16 M70.81%
2016 ยฃ1.85 M-16.22%
2015 ยฃ2.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
ยฃ0.48 B 42,566.55% Jersey
Novavax
NVAX
ยฃ0.76 B 67,947.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
ยฃ0.1 M-90.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
ยฃ16.4 M 1,350.79%๐Ÿ‡ฌ๐Ÿ‡ง UK